Skip to main content

Savara Inc

SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001160308

No open-market purchases or sales by Savara Inc insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.

Superinvestors holding SVRA, Q2 2026

See all superinvestors

No superinvestor reported holding SVRA in Q2 2026.